These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21964324)

  • 1. Drug challenge with sodium-channel blockade: improving phenotypic characterization of early repolarization.
    Ilkhanoff L; Knight BP
    Heart Rhythm; 2012 Feb; 9(2):240-1. PubMed ID: 21964324
    [No Abstract]   [Full Text] [Related]  

  • 2. Ajmaline attenuates electrocardiogram characteristics of inferolateral early repolarization.
    Roten L; Derval N; Sacher F; Pascale P; Wilton SB; Scherr D; Shah A; Pedersen ME; Jadidi AS; Miyazaki S; Knecht S; Hocini M; Jaïs P; Haïssaguerre M
    Heart Rhythm; 2012 Feb; 9(2):232-9. PubMed ID: 21914496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
    Nattel S
    Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
    Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
    Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current-to-load mismatch, Brugada ECG pattern, and the associated arrhythmogenesis.
    Di Diego JM
    Heart Rhythm; 2011 Jan; 8(1):119-20. PubMed ID: 20920601
    [No Abstract]   [Full Text] [Related]  

  • 6. Ajmaline challenge: to stop or not to stop..
    Probst V; Le Marec H
    Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
    Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
    Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.
    Ensam B; Scrocco C; Johnson D; Wijeyeratne YD; Bastiaenen R; Gray B; Miles C; Ben-Haim Y; Papatheodorou S; Sharma S; Papadakis M; Devine B; Macfarlane PW; Behr ER
    Circulation; 2024 May; 149(21):1693-1695. PubMed ID: 38768273
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.
    Cheung CC; Mellor G; Deyell MW; Ensam B; Batchvarov V; Papadakis M; Roberts JD; Leather R; Sanatani S; Healey JS; Chauhan VS; Birnie DH; Champagne J; Angaran P; Klein GJ; Yee R; Simpson CS; Talajic M; Gardner M; Yeung-Lai-Wah JA; Chakrabarti S; Laksman ZW; Sharma S; Behr ER; Krahn AD
    JACC Clin Electrophysiol; 2019 Apr; 5(4):504-512. PubMed ID: 31000106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combinations of anti-arrhythmia agents and the heart conduction system].
    Pleskot M; Tilser P; Pidrman V
    Vnitr Lek; 1988 Jan; 34(1):23-30. PubMed ID: 3354214
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Letter: Cardiac automatism].
    Porciello PI; Domenichelli B
    G Ital Cardiol; 1973; 3(3):452-6. PubMed ID: 4766980
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways.
    Neuss H; Schlepper M
    Acta Cardiol; 1974; Suppl 18():279-88. PubMed ID: 4547643
    [No Abstract]   [Full Text] [Related]  

  • 16. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of anti-arrhythmia agents on intracardiac conduction].
    Kulbertus H; Collignon P
    Acta Cardiol; 1974; Suppl 18():241-50. PubMed ID: 4547514
    [No Abstract]   [Full Text] [Related]  

  • 18. Left Axis Deviation in Brugada Syndrome: Vectorcardiographic Evaluation during Ajmaline Provocation Testing Reveals Additional Depolarization Abnormalities.
    van der Ree MH; Vendrik J; Kors JA; Amin AS; Wilde AAM; Tan HL; Postema PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How safe is ajmaline challenge in patients with suspected Brugada syndrome?
    Nault I; Champagne J
    Heart Rhythm; 2013 Dec; 10(12):1875-6. PubMed ID: 24177371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.